Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00089583 · ClinicalTrials.gov registry record · Phase 2
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
A Phase 2 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00089583 is a Phase 2 study that has completed, run by ViiV Healthcare. The registered enrollment target is 110 participants.
The verdict
NCT00089583, a Phase 2 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
This is a 48-week study to collect information on the safety and activity of an investigational medicine in patients, ages 2 to 18 years old, with HIV infection .
Interventions
- DRUG Ritonavir
- DRUG LEXIVA (GW433908)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2004-07 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00089583
The ClinicalTrials.gov registry entry for NCT00089583 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ritonavir is the first listed.
NCT00089583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00089583 about?
NCT00089583 is a clinical study titled "48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection". This is a 48-week study to collect information on the safety and activity of an investigational medicine in patients, ages 2 to 18 years old, with HIV infection .
What is the current status of trial NCT00089583?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2004-07. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00089583?
The interventions under investigation include: Ritonavir (DRUG), LEXIVA (GW433908) (DRUG).
Who is sponsoring clinical trial NCT00089583?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.